SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients

Inflammatory Bowel Disease

T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease

J Crohns Colitis

Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A

doi: 10.1093/ecco-jcc/jjab147

Hepatology

Impaired antibacterial response of liver sinusoidal Vγ9⁺Vδ2⁺ T cells in patients with chronic liver disease

Gut

Rha MS, Han JW, Koh JY, Lee HS, Kim JH, Cho K, Kim SI, Kim MS, Lee JG, Park SH, Joo DJ, Park JY, Shin EC

doi: 10.1136/gutjnl-2020-322182

HepatologyFurther Publications

Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases

J Hepatol

Thuluvath PJ, Robarts P, Chauhan M

doi: 10.1016/j.jhep.2021.08.008

Hepatology

MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis

Hepatology.

Niehaus CE, Strunz B, Cornillet M, Falk CS, Schnieders A, Maasoumy B, Hardtke S, Manns MP, Rm Kraft A, Björkström NK, Cornberg M

doi: 10.1002/hep.31153.

Hepatology

High Intra-Patient Variability in Tacrolimus Exposure Is Not Associated with Immune-Mediated Graft Injury after Liver Transplantation

Transplantation.

Van Der Veer MAA, Nangrahary N, Hesselink DA, Erler NS, Metselaar HJ, Van Gelder T, Darwish Murad S

doi: 10.1097/TP.

Hepatology

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

Aliment Pharmacol Ther.

Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V

doi: 10.1111/apt.14627.

Hepatitis

Effects of Hepatitis B Surface Antigen on Virus-specific and Global T Cells in Patients With Chronic HBV infection

Gastroenterology.

Le Bert N, Gill US, Hong M, Kunasegaran K, Tan DZM, Ahmad R, Cheng Y, Dutertre CA, Heinecke A, Rivino L, Tan A, Hansi NK, Zhang M, Xi S, Chong Y, Pflanz S, Newell EW, Kennedy PTF, Bertoletti A

doi: 10.1053/j.gastro.2020.04.019.

Hepatology

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

BMC Gastroenterol.

Ngwa T, Orman E, Gomez EV, Vuppalanchi R, Kubal C, Chalasani N, Ghabril M

doi: 10.1186/s12876-019-1155-1.

Further Publications

Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study

Gastroenterology

Ge J, Pletcher MJ, Lai JC, N3C Consortium.

doi: 10.1053/j.gastro.2021.07.010

Related content

T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease

Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with chronic liver disease

Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases

MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis

High Intra-Patient Variability in Tacrolimus Exposure Is Not Associated with Immune-Mediated Graft Injury after Liver Transplantation

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

Effects of Hepatitis B Surface Antigen on Virus-specific and Global T Cells in Patients With Chronic HBV infection

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study

Impaired antibacterial response of liver sinusoidal Vγ9⁺Vδ2⁺ T cells in patients with chronic liver disease